Astrin Biosciences
PrivateLast Round
VC Round
Jun 11, 2024
Total Funding Raised
$399,678
Company Overview
Astrin Biosciences is a biotechnology company that develops diagnostic tools designed for early cancer detection and precision therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrin Biosciences Comparables
Compare Astrin Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mammogen | 89% | |
| Syantra Inc. | 87% | |
| Bcal Diagnostics Ltd | 77% |
Astrin Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 11, 2024 | ||||
| Grant | Jun 1, 2022 |
Key People
Founding team and executive leadership
Astrin Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 1, 2025
New board will support AI-enabled proteomics platform development.
- Dec 1, 2025
Developing an AI-enabled proteomics platform for early cancer detection.
Recent news
Latest coverage and updates
- hiresSep 16, 2026
Astrin hired Tanya Gupta as Medical Director on Sep 16th '26.
- attends_eventJul 30, 2026
Astrin attended event San Antonio Breast Cancer Symposium on Dec 1st '25.
Astrin Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access